Sampling circulating tumor cells for clinical benefits: how frequent?

Circulating tumor cells (CTCs) are cells shed from tumors or metastatic sites and are a potential biomarker for cancer diagnosis, management, and prognostication. The majority of current studies use single or infrequent CTC sampling points. This strategy assumes that changes in CTC number, as well a...

Descripción completa

Detalles Bibliográficos
Autores principales: Leong, Sai Mun, Tan, Karen ML, Chua, Hui Wen, Tan, Doreen, Fareda, Delly, Osmany, Saabry, Li, Mo-Huang, Tucker, Steven, Koay, Evelyn SC
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4488127/
https://www.ncbi.nlm.nih.gov/pubmed/26108208
http://dx.doi.org/10.1186/s13045-015-0174-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4488127/
https://www.ncbi.nlm.nih.gov/pubmed/26108208
http://dx.doi.org/10.1186/s13045-015-0174-9

Ejemplares similares